Jacqueline Dombroski

Vice President Regulatory Affairs, SIRNAOMICS

Professional Overview
Jacqueline Dombroski is an accomplished regulatory affairs executive with over 15 years of experience in the biopharmaceutical industry. She currently serves as the Vice President of Regulatory Affairs at SIRNAOMICS, where she oversees the strategic planning and execution of global regulatory strategies to support the company's pipeline of innovative RNA-based therapeutics.

Experience Summary

Current Role
As the Vice President of Regulatory Affairs at SIRNAOMICS, Jacqueline is responsible for leading the company's regulatory function, ensuring compliance with applicable laws and regulations, and proactively engaging with global regulatory bodies to facilitate the successful development and commercialization of SIRNAOMICS' drug candidates. She has played a pivotal role in navigating the complex regulatory landscape, securing critical approvals, and driving the company's growth in the highly competitive biotechnology sector.

Career Progression
Prior to her current role, Jacqueline held senior regulatory affairs positions at prominent biopharmaceutical companies, including Coherus Biosciences, Theravance Biopharma, Intercept Pharmaceuticals, and Allergan. Throughout her career, she has demonstrated a deep understanding of regulatory processes, a keen eye for strategic planning, and a proven ability to collaborate with cross-functional teams to achieve regulatory milestones.

Academic Background
Jacqueline holds a Bachelor of Science degree in Microbiology from the University of California, Davis, and a Master of Science degree in Regulatory Affairs from the University of Southern California. Her academic credentials, combined with her extensive industry experience, have positioned her as a respected thought leader in the field of regulatory affairs.

Areas of Expertise

• Global regulatory strategy development and implementation

• Regulatory submissions and communications with global health authorities

• Lifecycle management and post-approval regulatory support

• Compliance with applicable laws, regulations, and industry standards

• Collaboration with cross-functional teams to ensure successful drug development

Professional Impact
Throughout her career, Jacqueline has contributed to the successful development and approval of numerous biopharmaceutical products, playing a crucial role in advancing innovative therapies that have improved patient outcomes. Her strategic vision, regulatory expertise, and collaborative approach have made her a valuable asset to the organizations she has served.

Conclusion
Jacqueline Dombroski's impressive track record, combined with her deep industry knowledge and strategic leadership, make her a highly sought-after regulatory affairs expert in the biopharmaceutical sector. In her current role at SIRNAOMICS, she continues to drive the company's regulatory success, positioning it for continued growth and innovation in the field of RNA-based therapeutics.